Expertise in
38
conditions

Dr. Howard M. Kenney

Rheumatology
105 West 8th Avenue, Suite 6080W, 
Spokane, WA 
Offers Telehealth
48 Years of Experience
Expertise in
38
conditions
105 West 8th Avenue, Suite 6080W, 
Spokane, WA 

Overview

Howard Kenney is a Rheumatologist practicing medicine in Spokane, Washington. He has been practicing medicine for over 48 years.

Dr. Kenney is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Synovitis, Psoriatic Arthritis, Orchiectomy, and Craniectomy.

He is actively involved in clinical research, co-authoring 38 peer reviewed articles and participating in 9 clinical trials.

Specialties

Rheumatology

Licenses

Internal Medicine in ID

Hospital Affiliations

Kootenai Health
Newport Community Hospital
Lincoln Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 22 Less Insurance Carriers -

Locations

105 West 8th Avenue, Suite 6080W, Spokane, WA 99204

Additional Areas of Focus

Dr. Kenney has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 21, 2026
Intervention Type: Diagnostic test
A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
Enrollment Status: Completed
Publish Date: May 19, 2026
Intervention Type: Biological, Drug
Study Drugs: Pegloticase, Methotrexate
Study Phase: Phase 4
Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study
Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study
Enrollment Status: Active_not_recruiting
Publish Date: April 14, 2026
Intervention Type: Procedure, Device, Drug
Study Drug: Conventional Synthetic DMARD
Study Phase: Phase 3
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 3
A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving KRYSTEXXA® (Pegloticase) (MIRROR Open-Label [OL])
A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving KRYSTEXXA® (Pegloticase) (MIRROR Open-Label [OL])
Enrollment Status: Completed
Publish Date: June 26, 2024
Intervention Type: Biological, Drug, Dietary supplement
Study Phase: Phase 4
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Drug
Study Drug: TAK-079
Study Phase: Phase 1
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

38 Total Publications

Psoriasis colocalized within preceding vitiligo patches: A rare case of Wolf's isotopic response and literature review.
Psoriasis colocalized within preceding vitiligo patches: A rare case of Wolf's isotopic response and literature review.
Journal: JAAD case reports
Published: July 23, 2026
Similar Doctors
Expertise in
38
conditions
Dr. Eric C. Mueller
Rheumatology
Expertise in
38
conditions
Dr. Eric C. Mueller
Rheumatology
Referral may be required
Before you request

Arthritis Northwest PLLC

105 W 8th Ave Ste 6080, 
Spokane, WA 
 (0.1 miles away)
509-838-6500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Eric Mueller is a Rheumatologist practicing medicine in Spokane, Washington. Dr. Mueller is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Axial Spondyloarthritis (AxSpA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis, and Psoriatic Arthritis. Dr. Mueller is currently accepting new patients.

Expertise in
34
conditions
Dr. Michael C. Coan
Rheumatology
Expertise in
34
conditions
Dr. Michael C. Coan
Rheumatology
Referral may be required
Before you request

Arthritis Northwest PLLC

105 W 8th Ave Ste 6080, 
Spokane, WA 
 (0.1 miles away)
509-838-6500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Coan is a Rheumatologist practicing medicine in Spokane, Washington. Dr. Coan is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), and Rheumatoid Lung Disease. Dr. Coan is currently accepting new patients.

Expertise in
37
conditions
Expertise in
37
conditions
Referral may be required
Before you request

Inland NW ASC

105 W 8th Ave Ste 6080, 
Spokane, WA 
 (0.1 miles away)
509-838-6500
Languages Spoken:
English, German, Spanish, Swedish
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Butler is a Rheumatologist practicing medicine in Spokane, Washington. Dr. Butler is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Raynaud Phenomenon. Dr. Butler is currently accepting new patients.

Frequently Asked Questions about Dr. Howard M. Kenney

How do I make an appointment with Dr. Howard M. Kenney?

You can book an appointment with Dr. Howard M. Kenney by calling their office at 509-838-6500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Howard M. Kenney a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Howard M. Kenney is classified as an Elite expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Howard M. Kenney specialize in?

While Dr. Howard M. Kenney is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Synovitis, and Psoriatic Arthritis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Howard M. Kenney participate in research or clinical trials?

Yes. Dr. Howard M. Kenney has published 38 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Howard M. Kenney's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Howard M. Kenney accept my insurance?

Dr. Howard M. Kenney accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 509-838-6500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kenney's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 29 Advanced Conditions
View All 41 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile